COMBINATION
    32.
    发明申请
    COMBINATION 审中-公开
    组合

    公开(公告)号:WO2011062930A1

    公开(公告)日:2011-05-26

    申请号:PCT/US2010/056931

    申请日:2010-11-17

    Abstract: A novel combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1 - yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mTOR inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of MEK and/or mTOR is beneficial, e.g. cancer.

    Abstract translation: 包含MEK抑制剂N- {3- [3-环丙基-5-(2-氟-4-碘 - 苯基氨基)6,8-二甲基-2,4,7-三氧代-3,4,6 ,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其药学上可接受的盐或溶剂合物与mTOR抑制剂,包含其的药物组合物和使用这些组合的方法 以及用于治疗MEK和/或mTOR的抑制有益的病症的组合物,例如, 癌症。

    COMBINATION
    33.
    发明申请
    COMBINATION 审中-公开
    组合

    公开(公告)号:WO2011044415A1

    公开(公告)日:2011-04-14

    申请号:PCT/US2010/051909

    申请日:2010-10-08

    CPC classification number: A61K31/4155 A61K31/506 A61K45/06 A61K2300/00

    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N -{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and N -{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1 H -pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及一种治疗人类癌症的方法和用于治疗的药物组合物。 特别地,该方法涉及一种癌症治疗方法,其包括给予N- {3- [5-(2-氨基-4-嘧啶基)-2-(1,1-二甲基乙基)-1,3-噻唑-4-基) 吡啶-2-基] -2-氟苯基} -2,6-二氟苯磺酰胺或其药学上可接受的盐和N - {(1S)-2-氨基-1 - [(3-氟苯基)甲基]乙基} -5-氯-4 - (4-氯-1-甲基-1H-吡唑-5-基)-2-噻吩甲酰胺或其药学上可接受的盐。

    FLEXIBLE LAYER TRACKING WITH WEAK ONLINE APPEARANCE MODEL
    37.
    发明申请
    FLEXIBLE LAYER TRACKING WITH WEAK ONLINE APPEARANCE MODEL 审中-公开
    具有较弱在线外观模型的柔性层跟踪

    公开(公告)号:WO2007013885A2

    公开(公告)日:2007-02-01

    申请号:PCT/US2005/036585

    申请日:2005-10-13

    Abstract: Method for tracking an object recorded within a selected frame of a sequence of frames of video data, using a plurality of layers, where at least one object layer of the plurality of layers represents the object includes initializing layer ownership probabilities for pixels of the selected frame using a non-parametric motion model, estimating a set of motion parameters of the plurality of layers for the selected frame using a parametric maximization algorithm and tracking the object. The non-parametric motion model is optical flow and includes warping the mixing probabilities, the appearances of the plurality of layers, and the observed pixel data from the pixels of the preceding frame to the pixels of the selected frame to initialize the layer ownership probabilities for the pixels of the selected frame.

    Abstract translation: 用于使用多个层来跟踪记录在视频数据的帧的序列的选定帧内的对象的方法,其中多个层中的至少一个对象层表示对象包括初始化层 使用非参数运动模型对所选帧的像素的所有权概率,使用参数最大化算法估计所述多个层的一组运动参数并跟踪所述对象。 非参数运动模型是光流,并且包括使混合概率,多个层的出现以及从前一帧的像素到所选帧的像素的观察像素数据变形,以初始化用于 所选帧的像素。

    ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
    39.
    发明申请
    ESTROGEN RECEPTOR MODULATORS AND USES THEREOF 审中-公开
    雌激素受体调节剂及其用途

    公开(公告)号:WO2005018575A2

    公开(公告)日:2005-03-03

    申请号:PCT/US2004/027834

    申请日:2004-08-26

    IPC: A61K

    CPC classification number: C07K14/4705 C12N15/113 C12N2310/14

    Abstract: The present disclosure relates to the field of cellular tumorigenesis and cancer biology. More specifically, the present disclosure relates to tumorigenesis and cancer in estrogen-responsive cell types, including cell types such as testis, ovary and uterine tissues, mammary gland, brain, skeletal muscle, and lung tissues. The present disclosure further relates to compositions including polypeptides, oligopeptides, petidomimetics, antibodies, and nucleic acids, and pharmaceutical compositions, diagnostic kits, and therapeutic kits useful in the diagnosis or treatment of turnorigenesis in estrogen-responsive cell types.

    Abstract translation: 本公开涉及细胞肿瘤发生和癌症生物学领域。 更具体地,本公开涉及在雌激素反应性细胞类型中的肿瘤发生和癌症,包括诸如睾丸,卵巢和子宫组织,乳腺,脑,骨骼肌和肺组织的细胞类型。 本公开还涉及包含多肽,寡肽,比模拟物,抗体和核酸的组合物,以及可用于诊断或治疗雌激素反应性细胞类型中的转录因子的药物组合物,诊断试剂盒和治疗试剂盒。

Patent Agency Ranking